Hypertriglyceridemia: An underdiagnosed side effect of Capecitabine chemotherapy

Acta Oncologica

Volumn 49, Issue 2, 2010, Pages 262-263

  Orphanos, George S ^a   Stavrou, Nicos G ^a   Picolos, Michalis K ^b  

^a Ygia Polyclinic ^*  (Cyprus)

^b Alithias Endocrinology Center   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BEXAROTENE; BEZAFIBRATE; CAPECITABINE; ESTROGEN; FLUOROURACIL; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; INTERFERON; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METFORMIN; NEUROLEPTIC AGENT; OMEGA 3 FATTY ACID; PROTEINASE INHIBITOR; TAMOXIFEN; THIAZIDE DIURETIC AGENT;

ADENOCARCINOMA; ADULT; BREAST CANCER; CASE REPORT; CECUM CARCINOMA; DRUG MONITORING; HAND FOOT SYNDROME; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOTHYROIDISM; LETTER; MALE; NAUSEA; NEPHROTIC SYNDROME; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADENOCARCINOMA; ANTILIPEMIC AGENTS; ANTINEOPLASTIC AGENTS; BEZAFIBRATE; CECUM; DEOXYCYTIDINE; FLUOROURACIL; HUMANS; HYPERTRIGLYCERIDEMIA; INTESTINAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 76649143404     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/02841860903373708     Document Type: Letter

References (8)

1. Pejic RN, Lee DT. Hypertriglyceridemia. J Am Board Fam Med 2006;19:310-6.
2. roche Pharmaceuticals (2007) Package insert. Xeloda (capecitabine). MoH approved leafets July 2007.
3. Jones KL, valero v. Capecitabine-induced pancreatitis. pharmacotherapy 2003;23:1076-8.
4. Sela GB, Haim N. Uncontrolled hypertriglyceridemia induced by capecitabine: Case report and review of the literature. Cancer Chemother pharmacol 2009;63:779-82.
5. Koutras AK, Habeos IG, vagenakis AG, Kalofonos HP. Capecitabine-induced hypertriglyceridemia: A report of two cases. Anticancer Res 2006;26:2249-52.
6. Kurt M, Babaoglu MO, Yasar U, Shorbagi A, Guler N. Capecitabine-induced severe hypertriglyceridemia: Report of two cases. Ann pharmacother 2006;40:328-31.
7. Stathopoulos GP, Koutantos J, Lazaki H, Rigatos SK, Stathopoulos J, Deliconstantinos G. Capecitabine (xeloda) as monotherapy in advanced breast and colorectal cancer: Effectiveness and side-effects. Anticancer res 2007;27:1653-6.
8. Stathopoulos GP, Stergiou GS, perrea-Kostarelis DN, Dontas IA, Karamanos BG, Karayiannacos PE. et al. Infuence of 5-fuorouracil on serum lipids. Acta Oncol 1995;34:253-6.